Please login to the form below

Not currently logged in

Inovio Biomedical elects new Board members

Inovio Biomedical Corporation has announced the election of David J Williams and Keith H Wells to its Board

DNA vaccine design, development and delivery firm Inovio Biomedical Corporation has announced the election of David J Williams, former chairman and CEO of Sanofi Pasteur, and Keith H Wells, a senior member of the Biologics Consulting Group and former director of vaccine development for The Salk Institute, to its Board. 

Dr J Joseph Kim, president and CEO of Inovio, said: "These two business leaders each have multiple decades of experience leading and executing the development and commercialisation of cutting-edge vaccine technology and important new vaccines. Their expertise will be invaluable to Inovio as we advance a new generation of vaccines – DNA vaccines delivered using the potency-enhancing capabilities of electroporation – that are displaying superior results and potential to not only prevent but treat challenging infectious diseases and cancers."

26th October 2009


Featured jobs

Subscribe to our email news alerts


Add my company

SpotMe is the leading technology and service provider of enterprise engagement platforms with a focus on live events, virtual and...

Latest intelligence

Medopad: the up and coming unicorn transforming remote patient monitoring
Blue Latitude Health speaks to Medopad’s Martha Carruthers to learn how the start-up’s modular apps are helping patients with complex diseases....
If you’re not thinking segmentation, you’re not thinking
Having a background in market research I’ve been lucky to work on a number of customer segmentations in my time but working in creative communications it is still too rare...
Improving Outcomes in the Treatment of Opioid Dependence Highlights Report
The 16th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD)conference took place at the Hilton Madrid Airport hotel on 15–16 May 2018....